600671.SS · 天目药业
China A-shares · RS rating 95 · As of 2026-10-14
| Price | 22.72 CNY |
|---|---|
| 1-day change | -2.0% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 87 / 87 / 85 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 55 / 56 / 47 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +23.8% |
| Distance from 52-week high | +4.9% |
| Market cap (USD) | $416.5M |